Registration Header

Date: may 5, 2021

Start Time:10am CT (Chicago) | 5pm CET (paris)

Duration:60 minutes


In order to keep competitive, pharma firms and their partners must keep current with the latest developments in drug delivery. This webinar will bring together leading experts from various corners of the field to discuss new innovations, enhancements to existing methods, dosage issues, bioavailability concerns, and other pressing issues.


Ajinomoto Procaps


Annette Bak

Head of Advanced Drug Delivery, Pharmaceutical Sciences, R&D


Annette Bak leads the advance drug delivery team at AstraZeneca, where she has been instrumental in delivering new modality formulations for clinical studies, most notably vascular endothelial growth factor (VEGF) mRNA currently evaluated for cardiac regeneration, building intracellular drug delivery capabilities, and sponsoring initiatives on augmenting drug discovery with AI. She has a PhD in Pharmaceutical Chemistry from the University of Copenhagen, and an MBA from Pepperdine University in California on Change Management and Leadership. Prior to her current role, Bak worked for Amgen and Merck with responsibility for small molecule and peptide formulations.

Dr Ravi Srinivasan


i2O Therapeutics

Dr Ravi Srinivasan is an entrepreneurial biotech executive. He co-founded and serves as CEO of i2O Therapeutics whose mission is to develop oral biologics. He is passionate about developing breakthrough first-in-class drug products leveraging novel scientific discoveries and has a track record in leading companies from inception to exit, and developing products from concept through commercialization. His therapeutic areas of interest and experience are oncology, dermatology, ophthalmology and diabetes.

Sven Stegemann

Professor for Patient Centric Drug Product Development

Graz University of Technology

Sven Stegemann is professor of patient centric drug design and manufacturing at the Graz University of Technology. During his 28-year career in the pharmaceutical industry, he has advised major pharmaceutical companies on ways to improve formulation design, development and manufacture of pharmaceutical products including advanced drug delivery and manufacturing technologies and controls.

Robert O. Williams III

Professor, Division of Molecular Pharmaceutics and Drug Delivery Head

The College of Pharmacy at the University of Texas at Austin

In Williams’ laboratory, research centers on efforts to enhance drug solubility and dissolution through novel particle engineering technologies, including thin film freezing and precipitation processes. In 2019, the National Academy of Inventors named him a fellow for his body of work, including innovations in drug delivery.

Jenni Spinner


Jenni is an editor covering the pharmaceutical industry for She holds a Bachelor’s in Communications from the University of Illinois. Before joining OSP, she covered numerous industries, including food packaging, production and safety; concrete and masonry construction; and public works.

Jane Byrne

Senior Editor


Jane has more than 15 years of experience as a journalist on news titles and trade press. She now writes about the international biopharmaceutical industry: including vaccine development, biosimilars, cell and gene therapies and the regulatory landscape.

First Name
Last Name
Email Address
Business Activity
Job Title
Company Employees

Got a burning question about this topic? Send it to us using the box below and we will try to have it answered by our expert panelists. You are also welcome to ask questions on the live day

This Editorial Webinar is a free service provided to you by Outsourcing-Pharma. This service is sponsored by the partners named on this page and they would like to contact you about their products and services. Please let us know if you are happy for our partners to contact you:

By email:

Outsourcing-Pharma may use your contact data to keep you informed of its products and services by email or by phone. You can withdraw your marketing consent at any time by clicking the unsubscribe link in such email or by sending an email to

More information on our processing can be found in our Privacy Notice. By submitting this form, you acknowledge that you have read and understand our Privacy Notice